As methamphetamine use and addiction continues to rise in Oregon and across the country, CODA researchers have helped to expand options for treatment. Featured in January on NPR, a new
We are delighted to announce the election of our newest board member Terri Theisen, Principal Consultant at Portland’s T2 Group. Terri worked with CODA several years ago to help raise
Because addiction is a chronic, relapsing disorder, patients commonly need repeated courses of treatment for sustained remission. This recent article from Forbes magazine illustrates how the language we use can
The drug that reverses opioid overdoses is safe and easy to use. Read the full Slate article here.
In May of this year, secondary to challenges with the limited space and a small staff, CODA discontinued in-person services at our Gresham outpatient office. Using our newfound telehealth skills,
To support the Black Lives Matter movement, CODA invited its employees to donate to ACLU of Oregon, Self Enhancement, Inc., Southern Poverty Law Center, Black Parent Initiative, Coalition of Communities of Color and the Urban League of
A big thanks to the Hillsboro team and a big congratulations to interns, Maeve Swakhammer and Zoie Meyers, for recently completing their MSW at PSU and their concurrent internships with
Since 2017, the anesthetic drug fentanyl has been a key component in increasing deaths from people who use opioids. When fentanyl is mixed into opioids, it creates an often-fatal respiratory
Read the full Street Roots article here
Read the full article from the Seaside Signal here.
With all the difficult work of planning and implementation behind us, it’s hard to believe it’s been three months since CODA’s first Oregon coast location, Seaside Recovery Center, opened its
Starting Monday April 27th, CODA’s outpatient programs are again scheduling admissions for new patients. We have maintained our “same-day, next-day” model, meaning individuals seeking help from us can begin treatment